A comparison of normalization methods for high density oligonucleotide array data based on variance and bias BM Bolstad, RA Irizarry, M Åstrand, TP Speed Bioinformatics 19 (2), 185-193, 2003 | 9996 | 2003 |
Randomised clinical trial: the efficacy of a transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain AL Krarup, L Ny, M Åstrand, A Bajor, F Hvid‐Jensen, MB Hansen, ... Alimentary pharmacology & therapeutics 33 (10), 1113-1122, 2011 | 149 | 2011 |
Contrast normalization of oligonucleotide arrays M Åstrand Journal of Computational Biology 10 (1), 95-102, 2003 | 107 | 2003 |
Effect of tenapanor on serum phosphate in patients receiving hemodialysis GA Block, DP Rosenbaum, M Leonsson-Zachrisson, M Åstrand, ... Journal of the American Society of Nephrology 28 (6), 1933-1942, 2017 | 106 | 2017 |
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled … HJL Heerspink, A Kiyosue, DC Wheeler, M Lin, E Wijkmark, G Carlson, ... The Lancet 402 (10416), 2004-2017, 2023 | 54 | 2023 |
The effects of a novel metabotropic glutamate receptor 5 antagonist (AZD 2066) on transient lower oesophageal sphincter relaxations and reflux episodes in healthy volunteers WO Rohof, A Lei, DP Hirsch, L Ny, M Astrand, MB Hansen, ... Alimentary pharmacology & therapeutics 35 (10), 1231-1242, 2012 | 45 | 2012 |
Endocrine and behavioral traits in low-avoidance performing Sprague–Dawley rats K Uvnäs-Moberg, E Björkstrand, P Salmi, C Johansson, M Åstrand, ... Regulatory peptides 80 (1-2), 75-82, 1999 | 25 | 1999 |
Activity of neutrophil elastase reflects the progression of acute pancreatitis S Novovic, AM Andersen, M Nord, M Åstrand, T Ottosson, LN Jørgensen, ... Scandinavian journal of clinical and laboratory investigation 73 (6), 485-493, 2013 | 22 | 2013 |
Pharmacokinetic–pharmacodynamic modelling of platelet response to ticagrelor in stable coronary artery disease and prior myocardial infarction patients M Åstrand, C Amilon, D Röshammar, A Himmelmann, DJ Angiolillo, ... British Journal of Clinical Pharmacology 85 (2), 413-421, 2019 | 17 | 2019 |
A model of healing of Los Angeles grades C and D reflux oesophagitis: is there an optimal time of acid suppression for maximal healing? PO Katz, DA Johnson, D Levine, K Röhss, O Junghard, M Åstrand, ... Alimentary pharmacology & therapeutics 32 (3), 443-447, 2010 | 17 | 2010 |
Empirical Bayes models for multiple probe type microarrays at the probe level M Åstrand, P Mostad, M Rudemo BMC bioinformatics 9, 1-11, 2008 | 17 | 2008 |
Prevention of relapse of healed reflux esophagitis is related to the duration of intragastric pH> 4 DA Johnson, PO Katz, D Levine, K Röhss, M Åstrand, O Junghard, ... Journal of clinical gastroenterology 44 (7), 475-478, 2010 | 16 | 2010 |
Population pharmacokinetics/pharmacodynamics of ticagrelor in children with sickle cell disease C Amilon, M Niazi, A Berggren, M Åstrand, B Hamrén Clinical Pharmacokinetics 58, 1295-1307, 2019 | 14 | 2019 |
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study MM Heeney, MR Abboud, J Githanga, BPD Inusa, J Kanter, AD Michelson, ... Blood, The Journal of the American Society of Hematology 140 (13), 1470-1481, 2022 | 13 | 2022 |
Pharmacokinetics of roxadustat: a population analysis of 2855 dialysis-and non-dialysis-dependent patients with chronic kidney disease D Rekić, V Kerbusch-Herben, M Någård, J Chou, J Huang, C Bradley, ... Clinical Pharmacokinetics 60, 759-773, 2021 | 11 | 2021 |
Improved covariance matrix estimators for weighted analysis of microarray data M Åstrand, P Mostad, M Rudemo Journal of Computational Biology 14 (10), 1353-1367, 2007 | 11 | 2007 |
Model‐based characterization of the relationship between dapagliflozin systemic exposure and HbA1c response in patients with type 1 diabetes mellitus J Parkinson, W Tang, M Åstrand, J Melin, E Ekholm, B Hamrén, ... Diabetes, Obesity and Metabolism 21 (6), 1381-1387, 2019 | 7 | 2019 |
Effect of a novel metabotropic glutamate receptor 5 antagonist (AZD2066) on transient lower esophageal sphincter relaxations and reflux episodes in healthy males WO Rohof, A Lei, D Hirsch, M Åstrand, L Ny, MB Hansen, ... Gastroenterology 5 (140), S-66, 2011 | 6 | 2011 |
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged< 24 months BP Duniva Inusa, A Inati, P Maes, J Githanga, B Ogutu, MR Abboud, ... Pediatric Blood & Cancer 68 (5), e28977, 2021 | 4 | 2021 |
Normalization and differential gene expression analysis of microarray data M Åstrand PQDT-Global, 2008 | 4 | 2008 |